Marissa Reitsma

marissa reitsma profilephoto

Marissa Reitsma, PhD

  • Assistant Professor, Health Policy

Biography

Marissa Reitsma, PhD, is an Assistant Professor of Health Policy at Stanford University School of Medicine. She obtained her PhD in Health Policy at Stanford in 2024, during which time she was a Knight-Hennessy Scholar, Stanford Data Science Scholar, and NSF Graduate Research Fellow. Previously, she worked on the Global Burden of Disease Study at the Institute for Health Metrics and Evaluation. Reitsma develops computational models to quantify disease burden, evaluate the benefits and costs of interventions, and support evidence-based policies across a range of priorities in public health, with a focus on health equity.

Reitsma aims to build simulation models that integrate the overlapping risk factors, social determinants, and syndemic conditions that disproportionately impact marginalized populations and contribute to health inequities. She also investigates the potential for multimodal data synthesis to inform these models, improve population health decision-making, and reduce health disparities. Her work spans multiple communicable and non-communicable conditions linked to behavioral risk factors, including tobacco use, drug use, and obesity. During the COVID-19 pandemic, she collaborated closely with state and local public health agencies to inform their decision-making.

In The News

Medicare Advantage Illustration
News

Policy Brief: Increasing Fairness in Medicare Payment Algorithms

This policy brief introduces two algorithms that can promote fairer Medicare Advantage spending for minority populations.
Policy Brief: Increasing Fairness in Medicare Payment Algorithms
Illustration of a piggy bank and prescription drug
News

Extending Prescription Drug Inflationary Rebates to Commercial Health Plans

A new study by SHP's Marissa Reitsma and Michelle Mello finds that extending prescription drug rebates to commercial health plans could lead to big savings.
Extending Prescription Drug Inflationary Rebates to Commercial Health Plans
Elderly Woman with Cane
News

Examining Opportunities to Increase Savings From Medicare Price Negotiations

SHP's Marissa Reitsma and Michelle Mello conduct an original investigation that finds allowing the U.S. Centers for Medicare & Medicaid Services to negotiate prescription drug prices for Medicare may improve drug affordability.
Examining Opportunities to Increase Savings From Medicare Price Negotiations